Nifty

:

23997.55

Sensex

:

76913.50

-180.10 (-0.74%)
-582.86 (-0.75%)

Login

Nifty
Sensex

:
:

23997.55
76913.50

-180.10 (-0.74%)
-582.86 (-0.75%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

74/99

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

2900.70

04-May-2026

Open
High
Low
Previous Close

2868.4
2939
2868.4
2822.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

154129
449101409.7
3228
2329.9

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

35,289.32
34.78
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

35,399.94
0.99%
7.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.36
9.97
7.49

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.93
4.75
9.97

PAT CAGR (%)

10 Years
5 Years
3 Years

8.28
7.08
16.11

P:E (Median)

8 Years
5 Years
3 Years

26.99
33.78
35.93

P:BV (Average)

8 Years
5 Years
3 Years

5.92
6.81
8.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.78
21.03
24.25

Earnings Forecasts:

(Updated: 02-05-2026)

Description 2024 2025 2026 2027
Adj EPS 73.56 84.17 98.51 112.68
P/E Ratio 39.43 34.46 29.45 25.74
Revenue 4587.51 5366.98 6055.81 6763.58
EBITDA 1259.5 1449.42 1706.91 1949.07
Net Income 920.39 1058.78 1237.05 1412.51
ROA 19.07 19.97 20.13 19.85
P/B Ratio 9.62 8.14 6.98 5.95
ROE 25.02 25.38 25.14 24.41
FCFF 866.08 544.73 1068.39 1051.7
FCFF Yield 2.56 1.61 3.15 3.11
Net Debt -567.53 -763.1 -627.65 -680.07
BVPS 301.59 356.36 415.62 487.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 1,206.59 1,101.92 9.50% 1,220.24 1,128.91 8.09% 1,208.56 1,077.27 12.19% 1,013.94 926.07 9.49%
Expenses 865.64 765.59 13.07% 930.65 826.00 12.67% 879.16 761.44 15.46% 764.29 698.92 9.35%
EBITDA 340.95 336.33 1.37% 289.59 302.91 -4.40% 329.40 315.83 4.30% 249.65 227.15 9.91%
EBIDTM 28.26% 30.52% 23.73% 26.83% 27.26% 29.32% 24.62% 24.53%
Other Income 25.76 33.23 -22.48% 75.03 40.34 85.99% 40.63 28.37 43.21% 17.93 33.68 -46.76%
Interest 1.87 2.48 -24.60% 0.73 0.73 0.00% 0.73 0.72 1.39% 0.67 1.42 -52.82%
Depreciation 42.38 34.93 21.33% 41.92 33.32 25.81% 40.31 32.92 22.45% 38.76 33.47 15.81%
PBT 322.46 332.15 -2.92% 321.97 309.20 4.13% 328.99 310.56 5.93% 228.15 225.94 0.98%
Tax 77.42 79.70 -2.86% 72.44 74.22 -2.40% 74.02 74.53 -0.68% 34.72 63.25 -45.11%
PAT 245.04 252.45 -2.94% 249.53 234.98 6.19% 254.97 236.03 8.02% 193.43 162.69 18.89%
PATM 20.31% 22.91% 20.45% 20.81% 21.10% 21.91% 19.08% 17.57%
EPS 19.62 20.21 -2.92% 19.98 18.81 6.22% 20.41 18.90 7.99% 15.49 13.03 18.88%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 1,421.64 1,170.41 21.47% 1,374.84 1,146.13 19.95% 1,353.73 1,186.64 14.08% 1,302.65 1,144.92 13.78%
Expenses 1,088.23 873.26 24.62% 992.60 825.30 20.27% 1,025.90 875.47 17.18% 951.30 814.57 16.79%
EBITDA 333.41 297.15 12.20% 382.24 320.83 19.14% 327.83 311.17 5.35% 351.35 330.35 6.36%
EBIDTM 23.45% 25.39% 27.80% 27.99% 24.22% 26.22% 26.97% 28.85%
Other Income 61.43 18.11 239.20% 24.97 30.44 -17.97% 59.34 19.48 204.62% 26.33 26.47 -0.53%
Interest 2.36 6.07 -61.12% 5.10 7.91 -35.52% 3.39 6.02 -43.69% 5.26 0.73 620.55%
Depreciation 45.37 39.78 14.05% 43.51 35.97 20.96% 42.97 34.39 24.95% 41.29 33.97 21.55%
PBT 347.11 269.41 28.84% 358.60 307.39 16.66% 340.81 290.24 17.42% 331.13 322.12 2.80%
Tax 80.41 44.15 82.13% 84.83 74.51 13.85% 80.62 73.76 9.30% 75.79 76.35 -0.73%
PAT 266.70 225.26 18.40% 273.77 232.88 17.56% 260.19 216.48 20.19% 255.34 245.77 3.89%
PATM 18.76% 19.25% 19.91% 20.32% 19.22% 18.24% 19.60% 21.47%
EPS 21.28 17.97 18.42% 21.84 18.58 17.55% 20.76 17.27 20.21% 20.37 19.61 3.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,649.33 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 Net Sales Growth 9.80% 8.84% 16.41% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% Cost Of Goods Sold 1,044.46 833.45 892.98 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 Gross Profit 3,604.87 3,488.59 3,078.14 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 GP Margin 77.54% 80.72% 77.51% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% Total Expenditure 3,439.74 3,117.32 2,851.69 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 Power & Fuel Cost - 70.22 66.44 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 % Of Sales - 1.62% 1.67% 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% Employee Cost - 1,010.90 834.16 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 % Of Sales - 23.39% 21.01% 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% Manufacturing Exp. - 322.26 303.25 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 % Of Sales - 7.46% 7.64% 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% General & Admin Exp. - 414.55 362.85 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 % Of Sales - 9.59% 9.14% 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% Selling & Distn. Exp. - 377.46 313.06 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 % Of Sales - 8.73% 7.88% 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% Miscellaneous Exp. - 88.48 78.95 77.39 50.78 61.76 60.43 42.58 88.70 96.63 164.06 % Of Sales - 2.05% 1.99% 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% EBITDA 1,209.59 1,204.72 1,119.43 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 EBITDA Margin 26.02% 27.87% 28.19% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% Other Income 159.35 119.87 116.48 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 Interest 4.00 4.60 6.80 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 Depreciation 163.37 139.93 132.16 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 PBT 1,201.57 1,180.06 1,096.95 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 Tax 258.60 263.17 289.71 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 Tax Rate 21.52% 22.30% 26.41% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% PAT 942.97 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 PAT before Minority Interest 942.97 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.28% 21.21% 20.33% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% PAT Growth 6.41% 13.58% 44.48% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% EPS 75.50 73.41 64.63 44.73 57.63 54.09 35.32 31.37 34.23 40.02 33.78

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 5,452.86 4,648.10 4,208.71 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 Net Sales Growth 17.31% 10.44% 12.45% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% Cost Of Goods Sold 1,183.76 892.19 880.13 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 Gross Profit 4,269.10 3,755.91 3,328.58 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 GP Margin 78.29% 80.81% 79.09% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% Total Expenditure 4,058.03 3,388.60 3,036.77 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 Power & Fuel Cost - 70.34 66.57 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 % Of Sales - 1.51% 1.58% 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% Employee Cost - 1,089.69 900.34 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 % Of Sales - 23.44% 21.39% 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% Manufacturing Exp. - 322.39 303.29 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 % Of Sales - 6.94% 7.21% 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% General & Admin Exp. - 435.55 382.26 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 % Of Sales - 9.37% 9.08% 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% Selling & Distn. Exp. - 482.41 417.54 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 % Of Sales - 10.38% 9.92% 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% Miscellaneous Exp. - 96.03 86.64 88.62 57.27 51.62 64.33 84.19 92.11 104.04 245.92 % Of Sales - 2.07% 2.06% 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% EBITDA 1,394.83 1,259.50 1,171.94 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 EBITDA Margin 25.58% 27.10% 27.85% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% Other Income 172.07 94.50 84.60 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 Interest 16.11 20.73 7.21 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 Depreciation 173.14 144.11 135.40 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 PBT 1,377.65 1,189.16 1,113.93 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 Tax 321.65 268.77 297.76 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 Tax Rate 23.35% 22.60% 26.73% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% PAT 1,056.00 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 PAT before Minority Interest 1,056.00 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.37% 19.80% 19.39% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% PAT Growth 14.73% 12.77% 38.81% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% EPS 84.55 73.69 65.35 47.08 57.06 52.35 37.45 30.98 37.52 40.58 33.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,625.31 3,413.57 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 Share Capital 25.07 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 Total Reserves 3,595.06 3,382.65 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,484.60 1,113.74 Non-Current Liabilities 218.22 174.17 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 Long Term Provisions 80.27 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 Current Liabilities 710.72 629.19 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 Trade Payables 366.27 383.74 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 Other Current Liabilities 304.47 190.39 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 Short Term Provisions 39.98 55.06 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 Total Liabilities 4,554.25 4,216.93 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 Net Block 1,741.96 1,464.89 1,484.01 1,483.91 1,509.89 1,439.93 1,152.14 1,036.69 572.93 432.83 Gross Block 2,759.58 2,355.33 2,246.28 2,152.24 2,075.60 1,915.71 1,540.50 1,379.38 859.28 679.21 Accumulated Depreciation 1,017.62 890.44 762.27 668.33 565.71 475.78 388.36 342.69 286.35 246.38 Non Current Assets 1,978.19 1,775.77 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 Capital Work in Progress 176.27 256.45 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 Non Current Investment 43.13 37.09 42.99 42.99 17.89 18.63 18.26 18.26 17.26 17.25 Long Term Loans & Adv. 13.12 12.97 134.68 226.15 230.52 165.33 148.10 76.56 41.68 21.12 Other Non Current Assets 3.71 4.37 4.85 5.88 10.65 9.09 4.09 4.00 2.34 4.27 Current Assets 2,567.21 2,432.82 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 Current Investments 438.71 330.05 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 Inventories 739.29 677.79 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 Sundry Debtors 1,225.81 1,207.67 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 Cash & Bank 49.72 63.06 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 Other Current Assets 113.68 44.34 18.56 29.78 318.91 229.02 230.92 124.40 55.39 59.94 Short Term Loans & Adv. 82.29 109.91 83.12 81.39 271.91 177.91 137.20 12.71 48.26 58.02 Net Current Assets 1,856.49 1,803.63 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 Total Assets 4,545.40 4,208.59 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,790.29 3,567.36 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 Share Capital 25.07 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 Total Reserves 3,760.04 3,536.44 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,548.35 1,172.90 Non-Current Liabilities 42.13 40.82 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 Secured Loans 0.00 0.00 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 Long Term Provisions 80.27 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 Current Liabilities 996.10 895.25 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 Trade Payables 454.20 463.20 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 Other Current Liabilities 478.02 369.52 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 Short Term Provisions 63.88 62.53 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 Total Liabilities 4,828.52 4,503.43 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 Net Block 1,762.02 1,479.19 1,496.44 1,503.58 1,532.21 1,462.75 1,168.35 1,052.66 589.17 450.74 Gross Block 2,801.05 2,389.41 2,282.82 2,206.86 2,129.87 1,965.22 1,578.96 1,417.23 894.94 715.73 Accumulated Depreciation 1,039.03 910.22 786.38 703.28 597.66 502.47 410.61 364.57 305.77 264.99 Non Current Assets 1,985.49 1,773.02 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 Capital Work in Progress 176.27 256.45 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 Non Current Investment 25.24 18.58 25.10 25.10 0.00 12.28 12.99 7.58 0.00 0.00 Long Term Loans & Adv. 18.25 14.43 134.79 236.46 230.74 165.57 148.36 76.79 41.88 21.29 Other Non Current Assets 3.71 4.37 4.85 5.88 11.18 9.09 4.08 4.00 2.34 4.28 Current Assets 2,829.70 2,722.07 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 Current Investments 438.71 330.05 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 Inventories 903.85 828.36 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 Sundry Debtors 1,182.74 1,246.84 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 Cash & Bank 176.24 130.77 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 Other Current Assets 128.16 53.76 22.09 34.79 327.60 237.70 240.08 137.73 64.92 66.19 Short Term Loans & Adv. 89.36 132.29 89.39 85.14 275.55 182.96 143.45 23.11 56.29 63.66 Net Current Assets 1,833.60 1,826.82 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 Total Assets 4,815.19 4,495.09 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,053.80 735.35 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 PBT 1,180.06 1,096.95 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 Adjustment 69.38 49.31 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 Changes in Working Capital 86.19 -158.63 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 Cash after chg. in Working capital 1,335.63 987.63 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -281.83 -252.28 -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -349.60 105.02 -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 Net Fixed Assets -324.07 -156.03 -150.65 -121.31 -137.02 -244.98 -361.08 -327.21 -235.38 -212.66 Net Investments -114.70 186.12 -388.41 -7.97 -71.11 -2.77 117.64 -1.82 -104.79 -17.41 Others 89.17 74.93 37.75 63.24 45.45 131.84 106.56 127.90 0.51 90.68 Cash from Financing Activity -715.71 -1,047.70 -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 Net Cash Inflow / Outflow -11.51 -207.33 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 Opening Cash & Equivalents 61.78 268.85 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 Closing Cash & Equivalent 50.27 61.52 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,157.23 785.07 792.11 561.71 576.31 456.77 374.51 281.12 609.29 326.14 PBT 1,189.16 1,113.93 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 Adjustment 112.11 83.03 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 Changes in Working Capital 178.93 -99.76 66.85 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 Cash after chg. in Working capital 1,480.20 1,097.20 943.40 800.84 806.70 611.60 492.74 420.72 760.38 487.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -322.97 -312.13 -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -376.52 65.39 -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 Net Fixed Assets -324.07 -156.03 -150.65 -121.31 -137.02 -244.98 -361.08 -327.21 -235.38 -212.66 Net Investments -114.70 186.12 -388.41 -7.97 -71.11 -2.77 117.64 -1.82 -104.79 -17.41 Others 62.25 35.30 -20.54 55.18 -74.25 23.35 20.66 72.92 -42.95 21.00 Cash from Financing Activity -733.41 -1,051.06 -108.20 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 Net Cash Inflow / Outflow 47.30 -200.60 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 Opening Cash & Equivalents 129.49 329.83 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 Closing Cash & Equivalent 176.79 129.23 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 289.84 270.68 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 ROA 20.91% 18.68% 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% ROE 26.09% 24.26% 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% ROCE 33.66% 33.15% 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% Fixed Asset Turnover 1.75 1.78 1.59 1.50 1.37 1.27 1.21 1.64 2.37 2.64 Receivable days 99.10 97.40 105.33 104.55 100.41 96.19 88.09 76.59 68.73 68.58 Inventory Days 57.71 60.68 68.73 72.68 70.87 70.66 75.32 49.52 36.95 39.76 Payable days 164.23 150.57 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 Cash Conversion Cycle -7.42 7.51 35.15 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 Interest Cover 257.53 162.32 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 303.04 282.89 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 ROA 19.72% 17.73% 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% ROE 25.06% 23.49% 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% ROCE 32.87% 32.22% 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% Fixed Asset Turnover 3.43 3.42 3.19 1.56 1.43 1.46 1.37 1.84 2.49 2.76 Receivable days 49.80 52.69 52.87 94.50 93.66 87.08 81.62 67.06 63.41 65.84 Inventory Days 35.51 37.60 40.91 83.71 78.09 65.68 69.82 48.10 37.89 37.93 Payable days 187.66 183.71 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 Cash Conversion Cycle -102.34 -93.41 -63.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 Interest Cover 58.36 155.50 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29

Top Investors:

uti-flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

kotak small cap fund

canara robeco mutual fund a/c canara robeco small cap fund

aditya birla sun life trustee private limited a/c aditya birla sun life midcap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA concludes inspection at Ajanta Pharma’s Paithan manufacturing facility
22nd Apr 2026, 10:10 AM

The inspection was conducted from April 13, 2026, to April 21, 2026
Read More
Ajanta Pharma - Quarterly Results
31st Jan 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback